Search for: "Anda Pharmaceuticals, Inc"
Results 281 - 300
of 605
Sorted by Relevance
|
Sort by Date
26 Apr 2009, 5:10 pm
Eagle Pharmaceuticals Inc. 1:09-cv-00285; filed April 23, 2009 in the District Court of Delaware Infringement of U.S. [read post]
7 Jul 2008, 3:52 am
Nostrum Pharmaceuticals, Inc. et al. 3:08-cv-03309; filed July 2, 2008 in the District Court of New Jersey Infringement of U.S. [read post]
20 Mar 2008, 5:27 pm
The Court of Appeals for the Federal Circuit upheld a lower court ruling that Teva Pharmaceutical Industries Ltd. infringed two patents held by Pfizer Inc. for Celebrex, a non-steroidal anti-inflammatory drug (NSAID) used to treat osteoarthritis and rheumatoid arthritis. [read post]
31 Oct 2016, 11:33 am
The parties in this litigation are engaged in the development and sale of pharmaceuticals. [read post]
10 Sep 2012, 9:01 am
Galderma Laboratories Inc. v. [read post]
16 Oct 2014, 1:16 pm
Mutual Pharmaceutical Company, Inc. [read post]
1 Apr 2014, 8:55 am
Teva Pharmaceuticals USA, Inc., et al., C.A. [read post]
9 Jan 2014, 6:08 am
Supernus Pharmaceuticals, Inc., IPR2013-00368, IPR2013-00371, IPR2013-00372 (PTAB) by Robert F. [read post]
8 Jan 2009, 12:38 pm
On March 31, 2005, one year into the FDA review of the generic manufacturers' ANDA submissions, Defendants Aventis Pharmaceuticals, Inc., Sanofi-Aventis, and Sanofi-Aventi U.S., LLC (collectively "Aventis") filed a Citizen Petition pursuant to Section 505(j) of the Federal Food, Drug, and Cosmetic Act. [read post]
22 Jun 2011, 2:11 pm
Mutual Pharmaceutical. [read post]
28 Oct 2021, 7:40 am
While it was Judge Maltese’s court-commissioned report on APKS that grabbed media attention in recent weeks, the New York trial continues against remaining defendants Allergan Finance (a subsidiary of AbbVie Inc.), Teva Pharmaceutical Industries Ltd. and Anda, Inc. [read post]
28 Feb 2013, 7:46 am
As part of its ANDA filing, Accord alleged that the claims of the '209 patent are invalid and/or not infringed by Accord's product. [read post]
13 Feb 2014, 9:04 am
According to the complaint, the Cipla entities are engaged in the generic-pharmaceutical business. [read post]
10 Nov 2015, 2:19 pm
Patent 6,500,829 (“the ‘829 patent’”) was invalid as obvious and that claims were not infringed by Sandoz’s Abbreviated New Drug Application (“ANDA”). [read post]
23 Oct 2009, 1:00 pm
Teva Pharmaceuticals USA, Inc., Civ. [read post]
17 Jul 2018, 9:28 am
” Par Pharmaceutical, Inc. v. [read post]
3 Nov 2011, 9:55 am
Watson Pharmaceuticals, Inc., 629 F. [read post]
19 Sep 2010, 9:31 pm
• Defendants: Sun Pharma Global FZE; Sun Pharmaceutical Industries, Inc. [read post]
10 Jan 2010, 8:54 pm
Cobrek Pharmaceuticals, Inc. 1:10-cv-00112; filed January 7, 2009 in the Northern District of Illinois Infringement of U.S. [read post]
12 Jun 2011, 9:17 pm
.; Par Pharmaceutical Inc. [read post]
